Amtsgericht Stuttgart, 10.04.2024
MVS Pharma GmbH announced today that, in collaboration with its partner in India, Elvantine®-Amoxicillin BP 250 mg/5 ml has successfully passed compliance and laboratory tests. This marks a crucial step in ensuring the product meets all quality standards. This antibiotic dry juice for children features a raspberry flavor and is packaged with a German-language leaflet and a measuring cup marked in millilitre units.
Should shortages of children’s dry juices recur from autumn 2024, MVS Pharma GmbH will be able to import larger quantities swiftly and market them under the exemption regulation AMG § 79.5.
MVS Pharma operates its own local purchasing organization in India. Given that over 60% of all medicines are sourced from India, MVS Pharma GmbH is ideally positioned to respond promptly to other shortages of urgently needed medications and to import sufficient quantities of high-quality medicines to address temporary shortages effectively.
About MVS Pharma GmbH
MVS Pharma GmbH is a forward-thinking pharmaceutical company based in Leinfelden-Echterdingen, Germany, with a branch in India. Founded in 2021, the company specializes in providing high-quality, safe, and effective pharmaceutical solutions to address critical health challenges. MVS Pharma is driven by its commitment to patient safety, transparency, and regulatory compliance.
MVS Pharma is a manufacturer, with its own team of professionals and experts in each field. And because the main goal of the company is the well-being of its customers, it makes sure to create all its products using only the best raw materials, free from heavy metals, pesticides, plastic, etc. In addition, MVS Pharma is also working on further clinical research into rose hips for a natural treatment of osteoarthritis and pure fish oil, purified from heavy metals, protected against oxidation, and packaged under 7 other steps, which will guarantee its high quality.
For press & media inquiries, please contact:
Mihaela Ahchieva
Head of Public Relations
MVS Pharma GmbH
mihaela.ahchieva@mvs-pharma.com
